Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098404 · ClinicalTrials.gov registry record

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

A clinical trial of Cancer, sponsored by The University of Texas Medical Branch, Galveston.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT06098404: Recruiting study of Cancer, sponsored by The University of Texas Medical Branch, Galveston.

NCT06098404 is a study of Cancer that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 250 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098404, a study of Cancer, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.

Primary Outcome

Characterization of the fecal microbiome using a commercially available sampling kit and our lab's patented array for PCR at baseline

Conditions Studied

Study Locations (1)

Texas

  • The University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-04
Est. Completion 2026-10

What NCT06098404 shows while recruiting

NCT06098404 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06098404 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06098404 about?

NCT06098404 is a clinical study titled "Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study". The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.

What is the current status of trial NCT06098404?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-03-04. Estimated completion is 2026-10.

What conditions does trial NCT06098404 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT06098404?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098404 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06098404's enrollment target sits among peer trials

250 205th of 615 higher than 408 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06098404, the US trial registry maintained by the National Library of Medicine. NCT06098404 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.